The action is in an interesting "position". Naturally, there is no guarantee that there will be a rebound from the slope, so it may be better to wait for the blue level. One problem is that the company is unprofitable, with even higher rates can be a serious problem for growth and cause a decline to red values. In this case, the red marking is probably...
It looks like a cup with a handle. Whether there was a "handle" or there will still be a subjective question, but if the current week holds the level / the next Monday will be green, we can generally expect growth. In general, the height can be the height of the cup (should be). But the size of the handle is not bad either
FATE is an interesting company, just developing. There are about 480 thousand in cash, an annual loss of 173 thousand, Has 8 studies in 1 phase. Probably, it will “accumulate” one more year before significant phase studies (3), which corresponds to the negative scenario. And 2 in partnership with Janssen and Ono Pharma. Curious FT596 with rituximab and FT538 with...
It will probably take a long time to accumulate around 131-132, but there is potential. Good Fibonacci level and channel. Landmark blue level Globally, the action can be classified as a category that will feel neutral and positive in 2022. These are Life sciences tools and services and Medical devices and equipment (according to wfc) Zimmer Biomet Holdings is a...
You can also expect a continuation of the rebound. I would like to believe that the growth is not over (the last movement is very similar to the 5th waves of the 5th), but a rebound to the designated area can be expected. (There are two markup options. Yellow suggests that we will see a large and long correction, which may correspond to a possible accumulation...
Thoughts on the market from the series "witness to the collapse". Be careful about the market today and this week - it is pending. The index is growing, volumes are falling, there are daily bearish divergences for XLK by RSI, CMF, and it is the engine for the US500. How much more will it grow and will the divergences work out? - It is impossible to say for sure,...
There are divergences, it looks very dangerous, but it can still make a leap up to 255. Probably MS how we pull fibo 12/15/21 Morgan Stanley Maintains Equal-Weight 256.0 12/08/21 UBS Initiates Coverage On Sell 170.0 11/12/21 Keybanc Maintains Overweight 255.0 11/03/21 Morgan Stanley Maintains Equal-Weight 241.0
You can see very good upside potential for the stock. There is a breakthrough of a small inclined channel, you only need to secure it. An average growth of 13-15% can be expected. And for 2022, the oil sector is in the top growth for many investors. Also, the rise in oil prices for investment banks remains. From the point of view of a positive outlook, everything...